Glaxosmithkline | Zysk Brutto



Pre Tax Profit Zmiana Data
AbbVie USD 4.81B 1.54B 2024-12
Amgen USD 3.38B 111M 2024-12
AstraZeneca USD 3.4B 1.74B 2025-03
Aurora Cannabis CAD 32.07M 31.47M 2024-12
Bausch Health Companies USD -47000000 256M 2025-03
Bristol-Myers Squibb USD 2.97B 1.29B 2025-03
Canopy Growth CAD -121580000 9.67M 2024-12
Corcept Therapeutics USD 161.49M 108.55M 2024-12
Drreddys Laboratories 18.74B 431M 2024-12
Eli Lilly USD 3.46B 2.08B 2025-03
GlaxoSmithKline GBP 2.11B 1.55B 2025-03
Glaxosmithkline USD 1.66B 1.78B 2024-12
Indivior 59M 29M 2025-03
J&J USD 13.63B 8.21B 2025-03
Merck USD 5.22B 114M 2024-12
Novartis USD 4.66B 269M 2024-12
Pacira USD 8.71M 16.82M 2025-03
Perrigo USD 8.3M 143M 2025-03
Pfizer USD 4.44B 2.36B 2024-12
Prestige Brands USD 73.96M 6.19M 2025-03
Roche Holding CHF 1.78B 2.33B 2024-12
Sanofi EUR 2.16B 20M 2025-03
Supernus Pharmaceuticals USD 26.38M 45.36M 2024-12
Takeda JPY -107299000000 133.71B 2025-03
Teva Pharmaceutical Industries USD 294M 605M 2025-03
Zoetis USD 773M 144M 2024-12



Glaxosmithkline Zysk Brutto - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Jul 2025.